S‐1 Plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial
Oncologist - United States
doi 10.1634/theoncologist.2018-0901
Full Text
Open PDFAbstract
Available in full text
Date
January 16, 2019
Authors
Publisher
Alphamed Press